Charles Schwab’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.4M Buy
771,296
+86,753
+13% +$1.28M ﹤0.01% 1950
2025
Q1
$12.3M Buy
684,543
+22,940
+3% +$411K ﹤0.01% 1857
2024
Q4
$11.5M Buy
661,603
+94,194
+17% +$1.64M ﹤0.01% 1952
2024
Q3
$7.94M Sell
567,409
-1,184
-0.2% -$16.6K ﹤0.01% 2148
2024
Q2
$4.67M Buy
568,593
+13,121
+2% +$108K ﹤0.01% 2388
2024
Q1
$4.28M Buy
555,472
+15,985
+3% +$123K ﹤0.01% 2336
2023
Q4
$4.85M Sell
539,487
-26,432
-5% -$238K ﹤0.01% 2323
2023
Q3
$5.06M Buy
565,919
+25,566
+5% +$229K ﹤0.01% 2259
2023
Q2
$8.3M Buy
540,353
+38,023
+8% +$584K ﹤0.01% 1994
2023
Q1
$11.3M Buy
502,330
+39,219
+8% +$882K ﹤0.01% 1811
2022
Q4
$9.74M Buy
463,111
+269
+0.1% +$5.66K ﹤0.01% 1874
2022
Q3
$11.4M Sell
462,842
-7,305
-2% -$180K ﹤0.01% 1763
2022
Q2
$11.4M Sell
470,147
-1,733
-0.4% -$42K ﹤0.01% 1769
2022
Q1
$12.2M Buy
471,880
+13,560
+3% +$349K ﹤0.01% 1836
2021
Q4
$14.2M Sell
458,320
-5,559
-1% -$173K ﹤0.01% 1802
2021
Q3
$11.3M Sell
463,879
-176,236
-28% -$4.27M ﹤0.01% 1938
2021
Q2
$9.34M Sell
640,115
-35,535
-5% -$518K ﹤0.01% 2039
2021
Q1
$16.9M Buy
675,650
+117,340
+21% +$2.93M 0.01% 1653
2020
Q4
$15.2M Buy
558,310
+34,708
+7% +$946K 0.01% 1593
2020
Q3
$9.67M Buy
523,602
+120,248
+30% +$2.22M ﹤0.01% 1722
2020
Q2
$8.23M Buy
403,354
+57,292
+17% +$1.17M ﹤0.01% 1761
2020
Q1
$5.05M Buy
346,062
+5,551
+2% +$81K ﹤0.01% 1828
2019
Q4
$4.84M Buy
340,511
+3,076
+0.9% +$43.7K ﹤0.01% 2030
2019
Q3
$3.91M Buy
337,435
+18,671
+6% +$216K ﹤0.01% 2103
2019
Q2
$6.4M Buy
318,764
+26,358
+9% +$530K ﹤0.01% 1851
2019
Q1
$6.62M Buy
292,406
+17,807
+6% +$403K ﹤0.01% 1838
2018
Q4
$6.22M Buy
274,599
+5,331
+2% +$121K ﹤0.01% 1769
2018
Q3
$7.74M Sell
269,268
-32,266
-11% -$927K 0.01% 1796
2018
Q2
$8.22M Buy
301,534
+5,998
+2% +$164K 0.01% 1723
2018
Q1
$6.61M Buy
295,536
+5,791
+2% +$130K 0.01% 1785
2017
Q4
$6.11M Buy
289,745
+71
+0% +$1.5K ﹤0.01% 1812
2017
Q3
$7.21M Buy
289,674
+11,986
+4% +$298K 0.01% 1676
2017
Q2
$5.39M Buy
277,688
+73,067
+36% +$1.42M 0.01% 1771
2017
Q1
$3.78M Buy
204,621
+40,330
+25% +$745K ﹤0.01% 1919
2016
Q4
$3.11M Buy
164,291
+32,183
+24% +$609K ﹤0.01% 1976
2016
Q3
$2.96M Buy
132,108
+11,187
+9% +$250K ﹤0.01% 1936
2016
Q2
$2.15M Buy
120,921
+2,040
+2% +$36.3K ﹤0.01% 2037
2016
Q1
$1.62M Sell
118,881
-7,979
-6% -$109K ﹤0.01% 2145
2015
Q4
$2.45M Buy
126,860
+3,233
+3% +$62.4K ﹤0.01% 1972
2015
Q3
$2.51M Buy
123,627
+21,319
+21% +$432K ﹤0.01% 1936
2015
Q2
$3.39M Buy
102,308
+47,484
+87% +$1.57M ﹤0.01% 1800
2015
Q1
$1.31M Buy
54,824
+2,436
+5% +$58.4K ﹤0.01% 2269
2014
Q4
$642K Buy
52,388
+7,281
+16% +$89.2K ﹤0.01% 2537
2014
Q3
$407K Buy
45,107
+12,079
+37% +$109K ﹤0.01% 2662
2014
Q2
$388K Buy
+33,028
New +$388K ﹤0.01% 2739